Basic Information
EsoCap's vision is to improve the lives of patients affected by esophageal diseases. EsoCap, a privately held investment company based in Basel, Switzerland, has developed a novel solution designed to provide targeted and sustained localized treatment for the upper gastrointestinal tract.